Fill in the form below and our experts will get back to you within 1 business day.
CD Biosynsis engineers microbial platforms for industrial-scale biomanufacturing. From high-titer enzyme production to bio-based chemical synthesis, we help replace petroleum-derived processes with sustainable biological alternatives.
Serving the Industrial Biotechnology Sector
Chemical Manufacturers
Bio-based chemical producers
Enzyme Companies
Industrial enzyme suppliers
Biofuel Producers
Advanced biofuels developers
Biorefinery Operators
Lignocellulosic bioprocessing
End-to-end infrastructure for industrial-scale biomanufacturing
High-titer industrial enzymes
Microbial synthesis of commodity chemicals
Lignocellulosic utilization systems
High-productivity strain development
Industrial biotechnology must compete with established chemical processes on cost and performance. Our platform systematically reduces production costs through yield optimization and process intensification.
Industrial biotechnology requires cost competitiveness with established chemical processes. Our metabolic engineering platform reduces production costs through yield maximization and process optimization.
Industrial processes benefit from diverse carbon sources. We engineer strains that efficiently utilize agricultural residues, industrial waste streams, and unconventional feedstocks.
Laboratory success doesn't guarantee industrial performance. Our platform includes scale-up simulation, process analytical technology, and troubleshooting for commercial deployment.
Platform Approach
40% faster development
We engineer microorganisms for industrial-scale biomanufacturing. Our platform combines metabolic engineering, fermentation optimization, and process development to deliver production strains meeting economic requirements.
Develop high-yield platforms for cellulases, xylanases, proteases, and specialty enzymes exceeding 100 g/L for cost-effective industrial supply.
Engineer organic acids (lactic, succinic, itaconic), alcohols (ethanol, butanol), and platform chemicals as drop-in renewable alternatives.
Engineer consolidated bioprocessing strains for simultaneous enzyme production, biomass deconstruction, and product synthesis.
Develop engineered microorganisms for isobutanol, FAME, and terpenoid-based fuels matching fossil fuel combustion properties.
Engineer production strains for 2,3-butanediol, gamma-valerolactone, and green solvents as biodegradable petroleum alternatives.
Develop genomically stable production strains for long-duration fermentations addressing plasmid loss and fitness decline.
Why industry is transitioning to biological manufacturing
| Parameter | Chemical Inputs | Synthetic Biology |
|---|---|---|
| Reaction Conditions | High temperature and pressure, hazardous catalysts | Ambient temperature, aqueous conditions |
| Chemical Selectivity | Multiple steps and purification stages required | Single-cell synthesis with high stereoselectivity |
| Environmental Footprint | Significant emissions and hazardous waste | Reduced carbon footprint, biodegradable products |
| Feedstock Flexibility | Dependent on petroleum availability | Utilize diverse biomass and waste feedstocks |
| Process Modularity | Facility redesign for new products | Biological platforms adaptable to diverse products |
Industrial-scale capabilities for cost-competitive biomanufacturing development.
Systematic pathway optimization for maximum yield and productivity
Shake flask to 100,000L industrial fermenter technology transfer
PAT and real-time monitoring for process control
Equipment specification and commissioning support
We function as your external strain engineering and metabolic pathway team. Whether you need a single engineered chassis or a complete pathway optimization pipeline, we deliver publication-quality data and transfer-ready strains.
Each project is assigned a dedicated PhD-level scientist as primary contact, ensuring technical continuity and rapid decision-making throughout development.
Engage us for full end-to-end development or specific phases (strain engineering only, fermentation optimization only, etc.). Scale investment according to your validation needs.
All proprietary strains and sequences remain your exclusive property. We offer clean IP transfer with no residual license claims or downstream revenue sharing requirements.
In-house regulatory affairs team experienced with TSCA, FDA FCN, and ISO 14001 guidelines. We prepare submission-ready dossiers for your target markets.
Concept to pilot validation. Includes strain engineering, fermentation optimization, and greenhouse testing.
Genetic modification and characterization. Deliverables include sequence-confirmed strains and technical reports.
Process development and optimization. From lab-scale proof to pilot-scale production parameters.
Characterization, stability testing, and regulatory dossier preparation for submission.
Get answers to common questions about our industrial biotechnology solutions. our team for project-specific inquiries.
Our platform achieves titers exceeding 100 g/L for organic acids, 20% (v/v) for alcohols, and gram-scale enzyme production. Yields are optimized to theoretical maximums through systematic engineering.
Yes, we have engineered strains for lignocellulosic hydrolysates, industrial waste streams (glycerol, whey), C1 compounds (methanol, CO2), and mixed sugar streams with feedstock tolerance engineering.
We offer comprehensive scale-up from shake flask through 100,000L industrial fermenters including parameter translation, equipment specification, and on-site commissioning support.
All strains, sequences, and process developments transfer exclusively to clients with clean IP, no residual licenses, and complete documentation packages including strain construction history.
Regulatory classification depends on your final product and modification approach. We can engineer strains using methods that may qualify for streamlined review (e.g., self-cloning, site-directed mutagenesis). Our regulatory team provides guidance on TSCA, FDA FCN, and ISO 14001 requirements. We also support life cycle assessment (LCA) documentation for bio-based products. during the project design phase to ensure your strain aligns with your intended regulatory pathway.
Get a customized quote for your Industrial Biotechnology project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.